Literature DB >> 8186656

A study on the efficacy of a screening program for colorectal cancer in a small Japanese village.

H Nakama1.   

Abstract

A longitudinal study of the reduction in mortality was carried out to evaluate the efficacy of screening for colorectal cancer. A population-based screening program using the fecal occult blood test was conducted from 1982 to 1991 in the small village of Asahi, Nagano, Japan (index area). The efficacy of the screening program was measured by the standardized mortality ratio (SMR) for colorectal cancer. The SMR in the index area was 150 before screening (1972-1981) and 54 during screening (1982-1991). In addition to a significantly lower SMR in the latter period (P < 0.01), the change in the relative incidence--(D-B)/B, where D is the SMR during screening, and B is the SMR before screening--showed a 64% reduction. The SMR in Asahi was also compared with that in four neighboring villages (control area) not covered by the screening. The SMR in the control area was 133 before and 121 during screening, for a (D-B)/B value of -9%. The reduction in the relative incidence of colorectal cancer was thus significantly higher in the index area than in the control area (P < 0.01). These results confirm that the screening program conducted in the index area was effective as a preventive community measure in reducing mortality from colorectal cancer, and that the time trend assessment employed here is a useful method for evaluating the efficacy of cancer screening.

Entities:  

Mesh:

Year:  1994        PMID: 8186656     DOI: 10.1007/bf00184587

Source DB:  PubMed          Journal:  Clin Investig        ISSN: 0941-0198


  16 in total

Review 1.  Case-control studies of screening.

Authors:  S M Moss
Journal:  Int J Epidemiol       Date:  1991-03       Impact factor: 7.196

2.  The design of a study to assess occult-blood screening for colon cancer.

Authors:  V A Gilbertsen; T R Church; F J Grewe; J S Mandel; R B McHugh; L M Schuman; S E Williams
Journal:  J Chronic Dis       Date:  1980

3.  Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study.

Authors:  J S Mandel; J H Bond; T R Church; D C Snover; G M Bradley; L M Schuman; F Ederer
Journal:  N Engl J Med       Date:  1993-05-13       Impact factor: 91.245

4.  Basic issues in population screening for cancer.

Authors:  P Cole; A S Morrison
Journal:  J Natl Cancer Inst       Date:  1980-05       Impact factor: 13.506

5.  A case-control study of screening sigmoidoscopy and mortality from colorectal cancer.

Authors:  J V Selby; G D Friedman; C P Quesenberry; N S Weiss
Journal:  N Engl J Med       Date:  1992-03-05       Impact factor: 91.245

6.  Effect of fecal occult blood testing on mortality from colorectal cancer. A case-control study.

Authors:  J V Selby; G D Friedman; C P Quesenberry; N S Weiss
Journal:  Ann Intern Med       Date:  1993-01-01       Impact factor: 25.391

7.  Repeated screening for colorectal cancer with fecal occult blood test. A prospective randomized study at Funen, Denmark.

Authors:  O Kronborg; C Fenger; J Olsen; K Bech; O Søndergaard
Journal:  Scand J Gastroenterol       Date:  1989-06       Impact factor: 2.423

8.  Fecal occult blood screening for colorectal cancer in the general population. Results of a controlled trial.

Authors:  J D Hardcastle; N C Armitage; J Chamberlain; S S Amar; P D James; T W Balfour
Journal:  Cancer       Date:  1986-07-15       Impact factor: 6.860

9.  A case-control study of the effectiveness of cervical cancer screening in Osaka, Japan.

Authors:  T Sobue; T Suzuki; S Hashimoto; N Yokoi; I Fujimoto
Journal:  Jpn J Cancer Res       Date:  1988-12

10.  Mass screening for breast cancer: comparison of the clinical stages and prognosis of breast cancer detected by mass screening and in out-patient clinics.

Authors:  J Ota; T Horino; T Taguchi; T Ishida; M Izuo; M Ogita; R Abe; H Watanabe; T Morimoto; S Itoh
Journal:  Jpn J Cancer Res       Date:  1989-11
View more
  4 in total

1.  Detection rate of immunochemical fecal occult blood test for colorectal adenomatous polyps with severe dysplasia.

Authors:  H Nakama; A S Abdul Fattah; B Zhang; N Kamijo; K Fujimori; K Miyata
Journal:  J Gastroenterol       Date:  1997-08       Impact factor: 7.527

Review 2.  The impact of screening on colorectal cancer mortality and incidence: has it really made a difference?

Authors:  Ann G Zauber
Journal:  Dig Dis Sci       Date:  2015-03-05       Impact factor: 3.199

3.  Immunochemical fecal occult blood test is inadequate for screening test of stomach cancer.

Authors:  H Nakama; B Zhang
Journal:  Dig Dis Sci       Date:  2000-11       Impact factor: 3.199

Review 4.  Screening for colorectal cancer by immunochemical fecal occult blood testing.

Authors:  H Saito
Journal:  Jpn J Cancer Res       Date:  1996-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.